Inoculum-to-substrate ratio and solid content effects over in natura spent coffee grounds anaerobic digestion.

Coffee is the second most traded commodity worldwide, and its production is associated with the generation of a large number of residues, which are underused and disposed of in landfills. Notably, the coffee industry annually generates approximately 6 million tons of industrial spent coffee ground (ISCG) when extracting coffee flavorings to produce soluble coffee. That resource loss scenario has been highlighted in sustainable waste management contexts as an opportunity to improve the coffee circular economy. Despite ISCG bioconversion to methane potentially meets the waste-to-energy purposes of reducing residues disposal in landfills, decreasing greenhouse gas (GHG) emissions, and increasing renewable energy sources, data about anaerobic digestion (AD) of ISCG remains quite restricted. That limitation becomes more apparent owing to the lack of data focusing on AD key parameters for ISCG as substrate. This study assessed the influence of inoculum-to-substrate ratio (ISR) and the solid content influences on mesophilic (37 °C) ISCG-AD throughout the Response Surface Methodology (RSM) and Central Composite Design (CCD). Results revealed that both factors, ISR and solid content, should be kept above a certain threshold of 0.5 and 6.0 gTVS L-1 to ensure experimental reliability, as well as reproductively and above 1.0 and 8.0 gTVS L-1 to avoid underestimation on the MY potential achieved. Concerning ISCG-AD kinetics, the quadratic model optimum condition was at 1.36 and 14.83 gTVS L-1 for ISR and solid content, respectively. This optimum range for ISR and solid content could guide further development of process configurations for mono- and co-digestion of ISCG, avoiding underestimation of the MY potential and extended incubation periods.

Nifedipine treatment in preeclampsia reverts the increased erythrocyte aggregation to normal.

OBJECTIVES: Our objectives were to assess erythrocyte aggregation in hypertensive pregnancy and to evaluate the effect of the antihypertensive treatment on it. STUDY DESIGN: The mean entity of erythrocyte aggregation was determined by an automatic aggregometer in 57 pregnant women: 20 normotensive, seven chronically hypertensive, 10 chronically hypertensive with superimposed preeclampsia, and 20 with preeclampsia. Ten of the latter were subsequently treated by 40 mg/day oral nifedipine; the other 10 by 400 mg/day oral labetalol, to keep diastolic blood pressure < 90 mm Hg. Also, patients with superimposed preeclampsia were treated with 40 mg/day oral nifedipine. RESULTS: Erythrocyte aggregation was increased in all the hypertensive pregnant patients compared with the normotensive pregnant controls, regardless of both the onset (chronic or pregnancy-induced) of hypertension and the status of plasma macromolecules. Antihypertensive treatment with labetalol significantly reduced the aggregability of erythrocytes, whereas treatment with nifedipine reverted it to normal. CONCLUSIONS: Increased erythrocyte aggregation may be due to either conformational changes of the membrane occurring during hypertension or a redistribution of the ionic charges on the two surfaces of the membrane. The effect of nifedipine by restoring the ionic charges may be due to this latter event.